Lenalidomide induces degradation of IKZF1 and IKZF3
2014; Landes Bioscience; Volume: 3; Issue: 7 Linguagem: Inglês
10.4161/21624011.2014.941742
ISSN2162-402X
AutoresJan Krönke, Slater N. Hurst, Benjamin L. Ebert,
Tópico(s)Ubiquitin and proteasome pathways
ResumoLenalidomide and its analogs, thalidomide and pomalidomide, specifically inhibit growth of mature B-cell lymphomas, including multiple myeloma, and induce interleukin-2 (IL-2) release from T cells. We recently found that this results from activation of the CRBN-CRL4 E3 ubiquitin ligase to degrade the lymphoid transcription factors IKZF1 (Ikaros) and IKZF3 (Aiolos).
Referência(s)